NCT03089281: A reported trial by Boston Scientific Corporation
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03089281 |
|---|---|
| Title | Strategic Management to Optimize Response To Cardiac Resynchronization Therapy |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 1, 2017 |
| Completion date | Sept. 15, 2020 |
| Required reporting date | Sept. 15, 2021, midnight |
| Actual reporting date | Sept. 15, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |